Buscar
Mostrando ítems 1-10 de 6721
Análise comparativa do histórico da prestação de serviços e do desempenho do kit NAT HIV/HCV/HBV na hemorede NAT brasileira
(Fiocruz/Instituto de Tecnologia em Imunobiológicos, 2018)
Plataforma alternativa e flexível para o KIT NAT brasileiro
(Fiocruz/Instituto de Tecnologia em Imunobiológicos, 2018)
NAT2 and CYP2E1 polymorphisms and antituberculosis drug-induced hepatotoxicity in Peruvian patients
(Wiley, 2022)
Background: In Peru, 32,970 people were diagnosed with tuberculosis (TB) in 2019. Although TB treatment is effective, 3.4%–13% is associated with significant adverse drug reactions (ADR), considering drug-induced liver ...
Kit NAT HIV/HCV/HBV
(Ascom - Bio-Manguinhos - Instituto Tecnológico em Imunobiológicos, 2016)